Cargando…

High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021

This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.

Detalles Bibliográficos
Autores principales: Pathak, Kavya, Narang, Claire, Hwang, Thomas J., Espinoza, Juan C., Bourgeois, Florence T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641589/
https://www.ncbi.nlm.nih.gov/pubmed/36342722
http://dx.doi.org/10.1001/jamapediatrics.2022.4131
_version_ 1784826114291531776
author Pathak, Kavya
Narang, Claire
Hwang, Thomas J.
Espinoza, Juan C.
Bourgeois, Florence T.
author_facet Pathak, Kavya
Narang, Claire
Hwang, Thomas J.
Espinoza, Juan C.
Bourgeois, Florence T.
author_sort Pathak, Kavya
collection PubMed
description This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021.
format Online
Article
Text
id pubmed-9641589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-96415892022-11-28 High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021 Pathak, Kavya Narang, Claire Hwang, Thomas J. Espinoza, Juan C. Bourgeois, Florence T. JAMA Pediatr Research Letter This cohort study examines the characteristics of high-risk therapeutic devices approved by the US Food and Drug Administration for use in children and adolescents between 2016 and 2021. American Medical Association 2022-11-07 2023-01 /pmc/articles/PMC9641589/ /pubmed/36342722 http://dx.doi.org/10.1001/jamapediatrics.2022.4131 Text en Copyright 2022 Pathak K et al. JAMA Pediatrics. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Pathak, Kavya
Narang, Claire
Hwang, Thomas J.
Espinoza, Juan C.
Bourgeois, Florence T.
High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
title High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
title_full High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
title_fullStr High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
title_full_unstemmed High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
title_short High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
title_sort high-risk therapeutic devices approved by the us food and drug administration for use in children and adolescents from 2016 to 2021
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641589/
https://www.ncbi.nlm.nih.gov/pubmed/36342722
http://dx.doi.org/10.1001/jamapediatrics.2022.4131
work_keys_str_mv AT pathakkavya highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021
AT narangclaire highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021
AT hwangthomasj highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021
AT espinozajuanc highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021
AT bourgeoisflorencet highrisktherapeuticdevicesapprovedbytheusfoodanddrugadministrationforuseinchildrenandadolescentsfrom2016to2021